SCHEMBL810572

SCHEMBL810572

NC1CCCCC1NS(=O)(=O)c1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
LMNA P02545 3/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTR1A P08908 3/20 0.46
HTR7 P34969 3/20 0.46
PGR P06401 2/20 0.46
THRB P10828 2/20 0.45
FBP1 P09467 1/20 0.45
HSD11B1 P28845 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
MMP14 P50281 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27772043 0.84 ALDH1A1 (0.51) ALDH1A1LMNAGAASMN1; SMN2HTR1A
SCHEMBL810008 0.82 MAPK1 (0.59) ALDH1A1LMNAGAASMN1; SMN2THRB
SCHEMBL6055248 0.82 ALDH1A1 (0.65) ALDH1A1LMNAGAASMN1; SMN2THRB
SCHEMBL5796406 0.82 ALDH1A1 (0.65) ALDH1A1LMNAGAASMN1; SMN2THRB
SCHEMBL14455217 0.82 ALDH1A1 (0.65) ALDH1A1LMNAGAASMN1; SMN2THRB
SCHEMBL810835 0.82 ALDH1A1 (0.53) ALDH1A1LMNAGAASMN1; SMN2NPSR1
SCHEMBL29498546 0.81 MMP2 (0.55) ALDH1A1LMNAGAASMN1; SMN2HTR1A
SCHEMBL810320 0.78 KMT2A (0.52) ALDH1A1LMNASMN1; SMN2THRBNPSR1
SCHEMBL14455225 0.77 KDM4E (0.50) ALDH1A1LMNAGAASMN1; SMN2THRB
SCHEMBL12313542 0.77 KDM4E (0.50) ALDH1A1LMNAGAASMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2399895-B1 Process for producing optically active aliphatic fluoroalcohol KANTO KAGAKU (JP) 2018-08-08 EP disclosed
US-8558033-B2 Process for producing optically active aliphatic fluoroalcohol KANTO KAGAKU KABUSHIKI KAISHA (JP) 2013-10-15 US disclosed
US-20110319671-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL KANTO KAGAKU KABUSHIKI KAISHA (JP) 2011-12-29 US disclosed
EP-2399895-A2 Process for producing optically active aliphatic fluoroalcohol Kanto Kagaku Kabushiki Kaisha (JP) 2011-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319671-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL ADH1A, ADH1C, ADH5 ALDH1A1 5/4885LMNA 3133/4885GAA 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.